Aucta Pharmaceuticals, Inc. (AUCTA, Latin-improved, enhanced) is a technology based company focusing on the development and commercialization of Branded Specialty Products.
Aucta is a pharmaceutical company creating better products of proven molecules using 505(b)(2) regulatory pathway. Through innovation, Aucta is creating new therapeutics, including new dosage forms, new dosing regimens and new indications.
Aucta has a clear therapeutic focus in CNS , Dermatology, and Pediatrics. We are committed to be patient centric by continuously bringing improved forms of proven molecules into the market place.
Aucta has operations in both New Jersey, U.S. and Shanghai, China.